v3.25.2
Investment in Associates and Joint Ventures (Tables)
12 Months Ended
Dec. 31, 2024
Investment in Associates and Investments in Investees [Abstract]  
Schedule of Fair Value of the Investment

The table below summarizes the fair value of the investment in MitoCareX:

 

Balance at January 1, 2022  $
-
 
Investment date March 31, 2022   700 
Equity losses from investment in MitoCareX   (109)
      
Balance at December 31, 2022  $591 
      
Investment following achievement of first milestone   400 
Equity losses from investment in MitoCareX   (210)
Balance at December 31, 2023  $781 
      
Investment following achievement of second milestone  $600 
Equity losses from investment in MitoCareX   (429)
Balance at December 31, 2024  $952